ZimVie Study Shows Surface Tech May Reduce Implant Infections

New Research Highlights Bacterial Adhesion Findings

A recent scientific study published in the Journal of Biomedical Materials Research suggests that the surface texture of ZimVie Inc.’s premium dental implants may help reduce the risk of peri-implant infections compared to other commercial implants. The research specifically examined the company’s dual acid-etched coronal surface technology featured in their T3 PRO and TSX Implants.

Understanding the Technical Innovation

The study, “The Role of Implant Coronal Surface Properties on Early Adhesion of Streptococcus Oralis—An In Vitro Comparative Study,” addresses a crucial challenge in dental implantology. While rough surfaces at implant tops are designed to maintain crestal bone levels, they can potentially encourage bacterial adhesion, leading to complications. The research identified a specific roughness threshold that proves significant for bacterial adhesion patterns.

Research Director Hai Bo Wen of ZimVie emphasized the growing concern in the field, stating, “The prevalence of peri-implant mucositis (inflammation) and peri-implantitis has been on the rise in recent decades.” He added that the company takes pride in how their “Contemporary Hybrid Surface technologies have demonstrated success in helping mitigate this concern in today’s dental implantology field.”

Product Portfolio Details

The TSX Implants, introduced in 2022, are engineered for immediate extraction and standard loading protocols, featuring the Contemporary Hybrid Surface combination with coronal DAE. These implants are specifically designed to provide reliable performance in both soft and dense bone conditions.

Similarly, the T3 PRO Implant line, also launched in 2022, incorporates the proprietary Osseotite surface on the implant collar combined with a rougher grit-blasted implant body. The system is designed to achieve high primary stability and support immediate function.

Company Background

ZimVie Inc. (Nasdaq: ZIMV) operates globally in the dental market from its headquarters in Palm Beach Gardens, Florida. The company focuses on developing comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. Their research continues to contribute to the advancement of dental implant technology and patient care.